Back
Protagonist Therapeutics Vs. Ryan Specialty Holdings Industry Stock Comparison
Sell
45
PTGX
Protagonist Therapeutics
Last Price:
44.54
Seasonality Move:
15.58%
Buy
57
RYAN
Ryan Specialty Holdings
Last Price:
66.01
Seasonality Move:
3.62%
Sell
45
Protagonist Therapeutics (PTGX)
is a Sell
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $44.56. The Score for PTGX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- PTGX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Ryan Specialty Holdings (RYAN)
is a Buy
Is Ryan Specialty Holdings a Buy, Sell or Hold?
- The current Ryan Specialty Holdings [RYAN] share price is $66.00. The Score for RYAN is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- RYAN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $44.56
The current trend is moderately bearish and PTGX is experiencing slight selling pressure.
RYAN Stock Price Chart
What is Ryan Specialty Holdings's stock price today?
-
The Ryan Specialty Holdings share price today is $66.00
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYAN is experiencing selling pressure, which indicates risk of future bearish movement.
PTGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.25 | Buy |
| Relative Strength Index (14 RSI): | 52.9 | Buy |
| Chaikin Money Flow: | -305217 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (42.27 - 46.11) | Buy |
| Bollinger Bands (100): | (31.37 - 42.51) | Buy |
RYAN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.66 | Buy |
| Relative Strength Index (14 RSI): | 58.94 | Buy |
| Chaikin Money Flow: | -379692 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (63.17 - 65.51) | Buy |
| Bollinger Bands (100): | (55.02 - 64.28) | Buy |
PTGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 45.8 | Sell |
| 20-day SMA: | 44.7 | Sell |
| 50-day SMA: | 41.62 | Buy |
| 200-day SMA: | 31.64 | Buy |
| 8-day EMA: | 45.48 | Sell |
| 20-day EMA: | 44.64 | Sell |
| 50-day EMA: | 41.77 | Buy |
| 200-day EMA: | 33.01 | Buy |
RYAN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 64.98 | Buy |
| 20-day SMA: | 64.35 | Buy |
| 50-day SMA: | 63.71 | Buy |
| 200-day SMA: | 53.82 | Buy |
| 8-day EMA: | 65.44 | Buy |
| 20-day EMA: | 64.67 | Buy |
| 50-day EMA: | 63.1 | Buy |
| 200-day EMA: | 55.88 | Buy |
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.18 per share, an increase next quarter of $0.26 per share, an increase this year of $4.50 per share, and a decrease next year of $2.97 per share.
Ryan Specialty Holdings Earnings Growth & RYAN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, an increase next quarter of $0.11 per share, an increase this year of $0.43 per share, and an increase next year of $0.43 per share.
Protagonist Therapeutics Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ryan Specialty Holdings Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||